NasdaqCM - Delayed Quote • USD
BeyondSpring Inc. (BYSI)
At close: April 18 at 4:00 PM EDT
Pre-Market: 5:25 AM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | 1 |
| Avg. Estimate | 0 | 0 | 0 | -0.47 |
| Low Estimate | 0 | 0 | 0 | -0.47 |
| High Estimate | 0 | 0 | 0 | -0.47 |
| Year Ago EPS | -0.44 | -0.49 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 1 |
| Avg. Estimate | 30M | 340k | 1.35M | 1.4M |
| Low Estimate | 30M | 340k | -- | 1.4M |
| High Estimate | 30M | 340k | 31.01M | 1.4M |
| Year Ago Sales | 338k | 338k | 1.35M | 1.35M |
| Sales Growth (year/est) | 8,775.70% | 0.60% | 0.00% | 3.60% |
Earnings History
| CURRENCY IN USD | 3/31/2021 | 6/30/2021 | 9/30/2021 | 12/31/2021 |
|---|---|---|---|---|
| EPS Est. | -0.54 | -0.33 | -0.37 | -0.26 |
| EPS Actual | -0.44 | -0.49 | -0.47 | -0.24 |
| Difference | 0.1 | -0.16 | -0.1 | 0.02 |
| Surprise % | 18.50% | -48.50% | -27.00% | 7.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | -0.47 |
| 7 Days Ago | 0.48 | -0.34 | -1.13 | -0.47 |
| 30 Days Ago | 0.48 | -0.34 | -1.13 | -0.47 |
| 60 Days Ago | 0.48 | -0.34 | -1.13 | -0.47 |
| 90 Days Ago | 0.48 | -0.34 | -1.13 | -0.47 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2022) | Next Qtr. (Jun 2022) | Current Year (2022) | Next Year (2023) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | BYSI | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 0.80% |
| Next Qtr. | -- | -- | -- | 9.60% |
| Current Year | -- | -- | -- | 4.50% |
| Next Year | -- | -- | -- | 13.30% |
| Next 5 Years (per annum) | -159.60% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | Baird: Outperform | 5/2/2023 |
| Downgrade | Jefferies: Buy to Hold | 12/2/2021 |
| Downgrade | B of A Securities: Buy to Underperform | 12/2/2021 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 12/1/2021 |
| Maintains | HC Wainwright & Co.: Buy | 9/20/2021 |
| Initiated | Baird: Outperform | 9/9/2021 |
Related Tickers
WINT Windtree Therapeutics, Inc.
0.3398
-14.21%
CELU Celularity Inc.
3.2100
-3.02%
TSOI Therapeutic Solutions International, Inc.
0.0007
0.00%
IPIX Innovation Pharmaceuticals Inc.
0.0101
+1.00%
GLSI Greenwich LifeSciences, Inc.
12.89
-1.23%
BCEL Atreca, Inc.
0.0761
-1.81%
UBX Unity Biotechnology, Inc.
1.5100
+0.33%
XCUR Exicure, Inc.
0.5788
-0.21%
BIVI BioVie Inc.
0.4884
+3.61%
AURX Nuo Therapeutics, Inc.
0.8000
+6.67%